Credit Agricole’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.82M Hold
12,976
0.01% 703
2026
Q1
$3.35M Hold
12,976
0.01% 723
2025
Q4
$3.2M Buy
+12,976
New +$2.73M 0.01% 725
2025
Q1
Sell
-3,336
Closed -$523K 1299
2024
Q4
$523K Hold
3,336
﹤0.01% 1049
2024
Q3
$607K Buy
+3,336
New +$643K ﹤0.01% 917

Other funds holding KRYS

Credit Agricole's KRYS Position: Q2 2026 in Review

Credit Agricole held its Krystal Biotech (KRYS) position steady in Q2 2026 at 12,976 shares worth $4.82M. The position accounts for 0.01% of the portfolio, ranked #703.

Credit Agricole first reported a position in KRYS in Q3 2024 and has held it in 5 quarters since. 424 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Credit Agricole held 12,976 shares of Krystal Biotech worth $4.82M as of Q2 2026.
  • Credit Agricole left its Krystal Biotech share count unchanged in Q2 2026.
  • Krystal Biotech made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #703 holding.
  • Credit Agricole first reported a position in Krystal Biotech in Q3 2024 and has held it in 5 quarters since.
  • 424 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.